Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
HCPCS code
Name of the Procedure:
Injection, Doxorubicin Hydrochloride, Liposomal, Imported Lipodox, 10 mg (HCPCS Code: Q2049) Common names: Lipodox Injection, Liposomal Doxorubicin Injection Technical term: Liposomal Doxorubicin Hydrochloride Intravenous Injection
Summary
Liposomal Doxorubicin Hydrochloride is a specialized chemotherapy drug used to treat certain types of cancer. It is injected into the bloodstream and encapsulated in liposomes to improve drug delivery to cancer cells while reducing side effects on healthy tissues.
Purpose
Medical Conditions: Treats various cancers including ovarian cancer, multiple myeloma, and Kaposi's sarcoma. Goals or Outcomes: To shrink tumors, slow cancer growth, and manage symptoms.
Indications
Conditions: Ovarian cancer, multiple myeloma, AIDS-related Kaposi's sarcoma, and other specific cancers. Patient Criteria: Appropriate for patients who have not responded to conventional chemotherapy or who are at high risk for the side effects of traditional doxorubicin.
Preparation
Pre-procedure Instructions: Follow any fasting instructions if related to concurrent treatments. Adjust medications only if advised by your healthcare provider. Diagnostic Tests: Blood tests to assess liver, kidney function, and overall health.
Procedure Description
- Preparation: The healthcare team confirms the medication dose and prepares the injection site.
- Venous Access: A vein is accessed using an IV line.
- Injection: The liposomal doxorubicin is slowly infused over a set period, typically 30-60 minutes.
- Monitoring: Vital signs and patient condition are monitored during the infusion.
Tools/Equipment: IV line, infusion pump, and monitoring equipment. Anesthesia/Sedation: Usually not required. Local anesthetic may be used for venous access.
Duration
Typically, the infusion lasts between 30-60 minutes per session.
Setting
Performed in a hospital, outpatient clinic, or specialized cancer treatment center.
Personnel
Healthcare Professionals: Oncologist, chemotherapy nurse, and occasionally a pharmacist.
Risks and Complications
Common Risks: Nausea, fatigue, hair loss, and low blood counts. Rare Risks: Heart problems, severe allergic reactions, and hand-foot syndrome (skin reactions on hands and feet).
Benefits
Expected Benefits: Reduced tumor size, slowed cancer progression, and symptom management. Benefits might be recognized within a few weeks of treatment commencement.
Recovery
Post-procedure Care: Monitor for side effects, maintain hydration, and follow a balanced diet. Rest as needed. Recovery Time: Varies by individual; some may resume normal activities shortly after whereas others might need several days. Follow-up Appointments: Regular follow-ups for blood tests and to monitor the response to treatment.
Alternatives
Other Treatments: Traditional chemotherapy, radiation therapy, surgery, targeted therapy. Pros and Cons: Traditional chemotherapy may have more severe side effects. Targeted therapy and surgery are only applicable in certain cases and have their own specific risks.
Patient Experience
During the procedure, patients may feel a cold sensation at the injection site or mild discomfort. Post-procedure, there may be tiredness and nausea, which can be managed with medications. Ensuring comfort and addressing any pain or side effects promptly is crucial for a better overall experience.